Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

9811	Companies
196812	Keywords
127831	Articles
104640	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

BRIEF

published on 10/03/2024 at 12:03, 1 year 4 months ago

Pentixapharm Holding AG Lists on Frankfurt Stock Exchange

Frankfurt Stock Exchange IPO Biopharmaceuticals Radiopharmaceuticals Pentixapharm
PRESS RELEASE

published on 10/03/2024 at 11:58, 1 year 4 months ago

Pentixapharm Holding AG Completes IPO in the Prime Standard of the Frankfurt Stock Exchange
Pentixapharm Holding AG debuts in Prime Standard of Frankfurt Stock Exchange with IPO. Focus on radiopharmaceuticals for blood cancers

Frankfurt Stock Exchange IPO Biopharmaceutical Radiopharmaceuticals Pentixapharm
BRIEF

published on 10/01/2024 at 18:53, 1 year 4 months ago

Pentixapharm Holding AG fixe le prix de son introduction en bourse à 5,10 euros par action

Titres Bourse De Francfort Capitalisation Boursière Introduction En Bourse Pentixapharm
BRIEF

published on 10/01/2024 at 18:53, 1 year 4 months ago

Pentixapharm Holding AG Sets IPO Placement Price at EUR 5.10 per Share

Securities Frankfurt Stock Exchange IPO Market Capitalization Pentixapharm
PRESS RELEASE

published on 10/01/2024 at 18:48, 1 year 4 months ago

EQS-Adhoc: Pentixapharm Holding AG: Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed
Pentixapharm Holding AG sets IPO placement price at EUR 5.10 per share, placing all 3.9 million offer shares. Gross proceeds reach EUR 19.9 million. Post-money market capitalization at EUR 126.5 million

IPO Market Capitalization Pentixapharm Holding AG Placement Price Offer Shares
PRESS RELEASE

published on 09/24/2024 at 11:51, 1 year 4 months ago

Original-Research: Pentixapharm Holding AG (von BankM AG): n.a.
Pentixapharm Holding AG von BankM AG eingestuft. Präziser Theranostic-Ansatz mit validiertem Target. Potenzial in Präzisionsonkologie. Risikoadjustierte Bewertung des Eigenkapitals. Vollständige Analyse unter: http://www.more-ir.de/d/30855.pdf

BankM AG Pentixapharm Holding AG Theranostic-Ansatz Präzisionsonkologie Bewertung Eigenkapital
BRIEF

published on 09/23/2024 at 12:20, 1 year 4 months ago

Pentixapharm Holding AG fixe la fourchette de prix de son introduction en bourse

Bourse De Francfort Essais Cliniques Introduction En Bourse Produits Radiopharmaceutiques Pentixapharm
BRIEF

published on 09/23/2024 at 12:20, 1 year 4 months ago

Pentixapharm Holding AG Sets Price Range for Planned IPO

Frankfurt Stock Exchange Clinical Trials IPO Radiopharmaceuticals Pentixapharm
PRESS RELEASE

published on 09/23/2024 at 12:15, 1 year 4 months ago

Pentixapharm Holding AG Sets Price Range for Planned IPO
Pentixapharm Holding AG sets price range of EUR 4.70 to EUR 6.00 per share for planned IPO to fund product pipeline development in radioligand therapies

IPO Financial Resources Price Range Pentixapharm Holding AG Radioligand Therapies
BRIEF

published on 09/12/2024 at 15:05, 1 year 4 months ago

Pentixapharm Holding AG envisage une introduction en bourse à Francfort

Bourse De Francfort Introduction En Bourse Traitement Du Cancer Produits Radiopharmaceutiques Essais De Phase III

Accesswire

Published on 02/05/2026 at 15:10, 19 minutes ago

Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 39 minutes ago

High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 14:30, 59 minutes ago

Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Published on 02/05/2026 at 14:30, 59 minutes ago

Innodata to Report Fourth Quarter and Fiscal Year 2025 Results
Published on 02/05/2026 at 14:00, 1 hour 29 minutes ago

Organto Foods Inc. Expects Strong 2026 Growth Driven by Retail Wins and Expanded Supply Partnerships

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 15:15, 13 minutes ago

FIS SUCCESSFULLY COMPLETES €770 MILLION BOND ISSUANCE
Published on 02/05/2026 at 15:13, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 02/05/2026 at 15:12, 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Glencore plc
Published on 02/05/2026 at 15:12, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 02/05/2026 at 15:11, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 02/05/2026 at 11:30, 3 hours 59 minutes ago

Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 3 hours 59 minutes ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 21 hours 25 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 21 hours 25 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 21 hours 44 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31

View all LES ECHOS COMFI WIRE